| Patient | Booker T. Washington |
|---|---|
| Date of birth | 1967-04-05 |
| Identifiers | MRN HR-NI017-SYN; SSN (made up) 000-17-2284 |
| Document date | 2026-05-04 |
| Author | Lorraine Whitfield, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Severe hypertension with chronic kidney disease stage G3b and severely increased albuminuria in a 59-year-old man. Please assess the cause of the kidney disease, advise on kidney-protective therapy and blood pressure targets, and share his long-term care. [S]
Urgency: Soon, within one week; kidney ultrasound and echocardiogram booked for the morning of the consultation. [S]
Questions for the consultant:
Frontal headaches every week or so, palpitations, fatigue, slower concentration, blurred reading vision, and nocturia. Blood pressure 212/128 mmHg with no chest pain, breathlessness, or focal neurologic deficit; dilated funduscopy shows arteriolar narrowing and arteriovenous nicking without hemorrhages, exudates, or papilledema, and the ECG shows sinus rhythm with left ventricular hypertrophy by voltage, so we are treating as an outpatient. Creatinine 2.1 mg/dL (eGFR 36), BUN 34 mg/dL, potassium 4.4 and bicarbonate 21 mmol/L, urine albumin-creatinine ratio 820 mg/g, calcium 9.1 and phosphate 4.2 mg/dL, PTH 92 pg/mL, hemoglobin 12.6 g/dL with ferritin 210 ng/mL and transferrin saturation 26 percent, HbA1c 5.4 percent, LDL cholesterol 138 mg/dL. No earlier creatinine is on file. Never smoker; he travels often for work. Started today: amlodipine 10 mg and losartan 50 mg daily, and atorvastatin 20 mg daily [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-05-04 | active | S |
| Losartan 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-05-04 to 2026-05-11 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-05-04 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Severe hypertension with hypertensive kidney disease; synthetic modern diagnosis linked to the documented 1915 blood pressure of 220/150 | active | confirmed | I12.9 | S — Synthetic active diagnosis for the teaching episode; the 1915 findings remain D and the retrospective diagnosis remains R. |
| Chronic kidney disease stage G3b A3 (severely increased albuminuria), attributed to hypertensive nephrosclerosis | active | confirmed | N18.32 | S — Synthetic diagnosis supported by small echogenic kidneys and albuminuria; linked to the documented 1915 diagnosis of Bright's disease. |
| Hypertensive retinopathy, both eyes, without papilledema | active | confirmed | H35.033 | S — Synthetic funduscopic finding that echoes the documented failing vision. |
| Mild anemia of chronic kidney disease, iron replete; monitor | active | confirmed | D63.1 | S — Synthetic finding from the baseline hemoglobin and iron studies. |
| Hyperlipidemia | active | confirmed | E78.5 | S — Synthetic finding from the baseline LDL cholesterol. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1911 | Assault in New York City with two large scalp lacerations and a torn ear; recovered without apparent sequelae | D (CLM-0005) |
| 1911 | Chronic indigestion, worse when traveling; several days of treatment at the Battle Creek Sanitarium in 1911 | D (CLM-0005) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died in Malden, West Virginia, in 1876 (other accounts give 1874); cause not recorded in the cited source | D (CLM-0003) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-04 | Body height | 170 | cm | S |
| 2026-05-04 | Body weight | 71 | kg | S |
| 2026-05-04 | Body mass index (BMI) [Ratio] | 24.6 | kg/m2 | S |
| 2026-05-04 | Systolic blood pressure | 212 | mm[Hg] | S |
| 2026-05-04 | Diastolic blood pressure | 128 | mm[Hg] | S |
| 2026-05-04 | Heart rate | 88 | /min | S |
| 2026-05-04 | Respiratory rate | 16 | /min | S |
| 2026-05-04 | Body temperature | 36.8 | Cel | S |
| 2026-05-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-04 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-05-04 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-05-04 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 21 | mmol/L | 22-29 mmol/L | Low | S |
| 2026-05-04 | Urea nitrogen [Mass/volume] in Serum or Plasma | 34 | mg/dL | 6-24 mg/dL | High | S |
| 2026-05-04 | Creatinine [Mass/volume] in Serum or Plasma | 2.1 | mg/dL | 0.74-1.35 mg/dL | High | S |
| 2026-05-04 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 36 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 2026-05-04 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-05-04 | Calcium [Mass/volume] in Serum or Plasma | 9.1 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-05-04 | Phosphate [Mass/volume] in Serum or Plasma | 4.2 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 2026-05-04 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 92 | pg/mL | 15-65 pg/mL | High | S |
| 2026-05-04 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-05-04 | Ferritin [Mass/volume] in Serum or Plasma | 210 | ng/mL | 30-400 ng/mL | Normal | S |
| 2026-05-04 | Iron saturation [Mass Fraction] in Serum or Plasma | 26 | % | 20-50% | Normal | S |
| 2026-05-04 | Thyrotropin [Units/volume] in Serum or Plasma | 1.8 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-05-04 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 2026-05-04 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 138 | mg/dL | <=99 mg/dL | High | S |
| 2026-05-04 | Albumin/Creatinine [Mass Ratio] in Urine | 820 | mg/g | <=30 mg/g | High | S |
| 2026-05-04 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S |